ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 157 filers reported holding ASCENDIS PHARMA A/S in Q2 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,637 | +2931.5% | 17,482 | +2775.3% | 0.00% | – |
Q2 2023 | $54 | -99.3% | 608 | -99.1% | 0.00% | -100.0% |
Q1 2023 | $7,388 | +6.7% | 68,902 | +21.5% | 0.00% | 0.0% |
Q4 2022 | $6,926 | -99.9% | 56,707 | -54.6% | 0.00% | -78.6% |
Q3 2022 | $12,889,000 | -4.4% | 124,821 | -13.9% | 0.01% | +75.0% |
Q2 2022 | $13,483,000 | +13118.6% | 145,044 | +16668.1% | 0.01% | – |
Q1 2022 | $102,000 | -39.3% | 865 | -31.0% | 0.00% | – |
Q4 2021 | $168,000 | -98.6% | 1,254 | -98.3% | 0.00% | -100.0% |
Q3 2021 | $11,637,000 | +12830.0% | 73,009 | +10558.2% | 0.01% | – |
Q2 2021 | $90,000 | -82.7% | 685 | -83.0% | 0.00% | – |
Q1 2021 | $520,000 | -28.1% | 4,039 | -6.9% | 0.00% | – |
Q4 2020 | $723,000 | +13.7% | 4,337 | +5.2% | 0.00% | – |
Q3 2020 | $636,000 | +8.0% | 4,121 | +3.5% | 0.00% | – |
Q2 2020 | $589,000 | +1491.9% | 3,983 | +1110.6% | 0.00% | – |
Q1 2020 | $37,000 | -28.8% | 329 | -13.0% | 0.00% | – |
Q4 2019 | $52,000 | -93.7% | 378 | -95.6% | 0.00% | -100.0% |
Q3 2019 | $829,000 | +2338.2% | 8,611 | +2789.6% | 0.00% | – |
Q2 2019 | $34,000 | -99.9% | 298 | -99.9% | 0.00% | -100.0% |
Q1 2019 | $24,259,000 | +559.2% | 206,111 | +250.9% | 0.02% | +466.7% |
Q4 2018 | $3,680,000 | +933.7% | 58,733 | +1070.0% | 0.00% | – |
Q3 2018 | $356,000 | +9.5% | 5,020 | +2.8% | 0.00% | – |
Q2 2018 | $325,000 | -5.8% | 4,883 | -7.2% | 0.00% | – |
Q1 2018 | $345,000 | +83.5% | 5,260 | +11.9% | 0.00% | – |
Q4 2017 | $188,000 | +3.9% | 4,700 | -6.0% | 0.00% | – |
Q3 2017 | $181,000 | – | 5,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 133,691 | $13,805,000 | 36.44% |
RA Capital Management | 7,567,900 | $781,462,000 | 16.67% |
Q Global Advisors, LLC | 145,209 | $16,699,000 | 11.49% |
BERYLSON CAPITAL PARTNERS, LLC | 51,000 | $5,266,000 | 8.70% |
Spyglass Capital Management LLC | 949,915 | $98,088,000 | 6.94% |
Paradigm Biocapital Advisors LP | 497,347 | $51,356,000 | 6.85% |
Avoro Capital Advisors LLC | 2,850,000 | $294,291,000 | 5.44% |
Deep Track Capital, LP | 1,000,000 | $103,260,000 | 4.73% |
Finepoint Capital LP | 123,400 | $12,742,000 | 4.19% |
Deep Track Capital, LP | 800,000 | $82,608,000 | 3.78% |